Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects

被引:494
作者
Gastaldelli, Amalia
Cusi, Kenneth
Pettiti, Maura
Hardies, Jean
Miyazaki, Yoshinori
Berria, Rachele
Buigoli, Emma
Sironi, Anna Maria
Cersosimo, Eugenio
Ferrannini, Ele
Defronzo, Ralph A.
机构
[1] CNR, Inst Clin Physiol, I-56100 Pisa, Italy
[2] Univ Texas, Hlth Sci Ctr, Dept Med, Div Diabet, San Antonio, TX USA
[3] Case Western Reserve Univ, Dept Obstet Gynecol, Cleveland, OH USA
[4] Univ Pisa, Dept Internal Med, Pisa, Italy
关键词
D O I
10.1053/j.gastro.2007.04.068
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background&Aims: Abdominal fat accumulation (Visceral/hepatic) has been associated with hepatic insulin resistance (IR) in obesity and type 2 diabetes (T2DM). We examined the relationship between visceral/hepatic fat accumulation and hepatic IR/accelerated gluconeogenesis (GNG). MethodS: In 14 normal glucose tolerant (NGT) (body mass index [BMI] = 25 +/- 1 kg/m(2)) and 43 T2DM (24 nonobese, BMI = 26 +/- 1; 19 obese, BMI = 32 1 kg/m(2)) subjects, we measured endogenous (hepatic) glucose production (3-H-3-glucose) and GNG ((H2O)-H-2) in the basal state and during 240 pmol/m(2)/min euglycemic-hyperinsulinemic clamp, and liver (1,17) subcutaneous (SAT)/visceral (VAT) fat content by magnetic resonance spectroscopy/magnetic resonance imaging. Results: LF was increased in lean T2DM compared with lean NGT (18% +/- 3% vs 9% +/- 2%, P < .03), but was similar in lean T2DM and obese T2DM (18% 3% vs 22% +/- 3%; P = NS). Both VAT and SAT increased progressively from lean NGT to lean T2DM to obese T2DM. T2DM had increased basal endogenous glucose production (EGP) (NGT, 15.1 +/- 0.5; lean T2DM, 16.3 +/- 0.4; obese T2DM, 17.2 +/- 0.6 mu mol/min/kg(ffm); P =.02) and basal GNG flux (NGT, 8.6 +/- 0.4; lean T2DM, 9.6 +/- 0.4; obese T2DM, 11.1 +/- 0.6 mu mol/min/kg(ffm); P= .02). Basal hepatic IR index (EGP X fasting plasma insulin) was increased in T2DM (NGT, 816 54; lean T2DM, 1252 +/- 164; obese T2DM, 1810 +/- 210; P =.007). In T2DM, after accounting for age, sex, and BMI, both LF and VAT, but not SAT, were correlated significantly (P < .05) with basal hepatic IR and residual EGP during insulin clamp. Basal percentage of GNG and GNG flux were correlated positively with VAT (P < .05), but not with LF. LF, but not VAT, was correlated with fasting insulin, insulin-stimulated glucose disposal, and impaired FFA suppression by insulin (all P < .05). Conclusions: Abdominal adiposity significantly affects both lipid (FFA) and glucose metabolism. Excess VAT primarily increases GNG flux. Both VAT and LF are associated with hepatic IR.
引用
收藏
页码:496 / 506
页数:11
相关论文
共 40 条
  • [21] Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance
    Kabir, M
    Catalano, KJ
    Ananthnarayan, S
    Kim, SP
    Van Citters, GW
    Dea, MK
    Bergman, RN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 288 (02): : E454 - E461
  • [22] Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance
    Kelley, DE
    McKolanis, TM
    Hegazi, RAF
    Kuller, LH
    Kalhan, SC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (04): : E906 - E916
  • [23] Fatty liver - an additional and treatable feature of the insulin resistance syndrome
    Knobler, H
    Schattner, A
    Zhornicki, T
    Malnick, SDH
    Keter, D
    Sokolovskaya, N
    Lurie, Y
    Bass, DD
    [J]. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1999, 92 (02): : 73 - 79
  • [24] MEASUREMENT OF ABDOMINAL FAT WITH T1-WEIGHTED MR IMAGES
    LANCASTER, JL
    GHIATAS, AA
    ALYASSIN, A
    KILCOYNE, RF
    BONORA, E
    DEFRONZO, RA
    [J]. JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1991, 1 (03): : 363 - 369
  • [25] Contributions of gluconeogenesis to glucose production in the fasted state
    Landau, BR
    Wahren, J
    Chandramouli, V
    Schumann, WC
    Ekberg, K
    Kalhan, SC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02) : 378 - 385
  • [26] Liver pathology and the metabolic syndrome X in severe obesity
    Marceau, P
    Biron, S
    Hould, FS
    Marceau, S
    Simard, S
    Thung, SN
    Kral, JG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) : 1513 - 1517
  • [27] Association of nonalcoholic fatty liver disease with insulin resistance
    Marchesini, G
    Brizi, M
    Morselli-Labate, AM
    Bianchi, G
    Bugianesi, E
    McCullough, AJ
    Forlani, G
    Melchionda, N
    [J]. AMERICAN JOURNAL OF MEDICINE, 1999, 107 (05) : 450 - 455
  • [28] Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
    Marchesini, G
    Brizi, M
    Bianchi, G
    Tomassetti, S
    Bugianesi, E
    Lenzi, M
    McCullough, AJ
    Natale, S
    Forlani, G
    Melchionda, N
    [J]. DIABETES, 2001, 50 (08) : 1844 - 1850
  • [29] Matsuda M, 1997, DIABETES, V46, P265
  • [30] Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus
    Miyazaki, Y
    Glass, L
    Triplitt, C
    Wajcberg, E
    Mandarino, LJ
    DeFronzo, RA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (06): : E1135 - E1143